Karuna Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Karuna Therapeutics, Inc. has filed 460 SEC EDGAR filings since 29 Mar 2019

SEC filing history

Showing 376-400 of 460 matching filings.

Per page
25
Current page
16
4

PRIMARY DOCUMENT

Filing date
04 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Feb 2020
Reporting date
19 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jan 2020
Reporting date
22 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91054

SC 13D/A

Filing date
23 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jan 2020
Reporting date
09 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Jan 2020
Reporting date
03 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91054

ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D/A(#1) - KARUNA THERAPEUTICS, INC.

Filing date
13 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91054

SC 13G filing

Filing date
10 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38958

8-K

Filing date
02 Dec 2019
Reporting date
02 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Nov 2019
Reporting date
25 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38958

8-K

Filing date
21 Nov 2019
Reporting date
20 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-234756

424B4

Filing date
21 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-234756

EFFECT filing

Filing date
20 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38958

8-K

Filing date
18 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .